Drug manufacturers may forgo sales in Canada to increase average reference prices.
American pharmaceutical prices
U.S. pharmaceutical innovation has been disproportionately funded by U.S. consumers of patented drugs.
U.S. regulations blew up "inversion" merger between Pfizer and Allergan.
Canadians (and other non-Americans) benefit from research and development aimed primarily at the U.S. market.